Silent cerebral infarcts associated with cardiac disease and procedures

Nature Reviews Cardiology

Volumn 10, Issue 12, 2013, Pages 696-706

  Hassell, Mariëlla E C ^a   Nijveldt, Robin ^b   Roos, Yvo B W ^a   Majoie, Charles B L ^a   Hamon, Martial ^c   Piek, Jan J ^a   Delewi, Ronak ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; CLOPIDOGREL;

AORTA STENOSIS; BLOOD CLOTTING; BRAIN INFARCTION; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CORONARY ARTERY BYPASS GRAFT; DIAGNOSTIC PROCEDURE; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART DISEASE; HUMAN; INVASIVE PROCEDURE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATENT FORAMEN OVALE; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION;

ASYMPTOMATIC DISEASES; CARDIAC SURGICAL PROCEDURES; CEREBRAL INFARCTION; COGNITION DISORDERS; DEMENTIA, VASCULAR; DEPRESSION; DIAGNOSTIC IMAGING; HEART DISEASES; HUMANS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STROKE; TREATMENT OUTCOME;

EID: 84888640776     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2013.162     Document Type: Review

References (116)

1. Hamon, M., Baron, J. C., Viader, F. & Hamon, M. Periprocedural stroke and cardiac catheterization. Circulation 118, 678-683 (2008
2. Arboix, A & Alió, J. Cardioembolic stroke: Clinical features, specific cardiac disorders and prognosis. Curr. Cardiol. Rev. 6, 150-161 (2010
3. Bendszus, M. & Stoll, G. Silent cerebral ischaemia: Hidden fingerprints of invasive medical procedures. Lancet Neurol. 5, 364-372 (2006
4. Sacco, R. L. et al. An updated definition of stroke for the 21st century: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44, 2064-2089 (2013
5. Arboix, A. & Martí-Vilalta, J. L. Lacunar stroke. Expert Rev. Neurother. 9, 179-196 (2009
6. Vermeer, S. E., Koudstaal, P. J., Oudkerk, M., Hofman. A. & Breteler, M. M. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 33, 21-25 (2002
7. Price, T. R. et al. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults: The Cardiovascular Health Study. Stroke 28, 1158-1164 (1997
8. Kase, C. S. et al. Prevalence of silent stroke in patients presenting with initial stroke: The Framingham Study. Stroke 20, 850-852 (1989
9. Ricci, S. et al., Silent brain infarctions in patients with first-ever stroke: A community-based study in Umbria, Italy. Stroke 24, 647-651 (1993
10. Das, R. R. et al., Prevalence and correlates of silent cerebral infarcts in the Framingham Offspring Study. Stroke 39, 2929-2935 (2008
11. Wardlaw, J. M. et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 12, 822-838 (2013
12. Kloppenborg, R. P. et al. Cerebral small-vessel disease and progression of brain atrophy: The SMART MR study. Neurology 79, 2029-2036 (2012
13. Vermeer, S. E. et al., Silent brain infarcts and the risk of dementia and cognitive decline. N. Engl. J. Med. 348, 1215-1222 (2003
14. Fujikawa, T., Yamawaki, S. & Touhouda, Y. Incidence of silent cerebral infarction in patients with major depression. Stroke 24, 1631-1634 (1993
15. Yamashita, H. et al. Long-Term prognosis of patients with major depression and silent cerebral infarction. Neuropsychobiology 62, 177-181 (2010
16. Debette, S. et al., Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: The Framingham Offspring Study. Stroke 41, 600-606 (2010
17. Vermeer, S. E. et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: The Rotterdam Scan Study. Stroke 34, 1126-1129 (2003
18. Mullins, M. E. et al. CT and conventional and diffusion-weighted MR imaging in acute stroke: Study in 691 patients at presentation to the emergency department. Radiology 224, 353-360 (2002
19. Zhu, Y. C., Dufouil, C., Tzourio, C. & Chabriat, H. Silent brain infarcts: A review of MRI diagnostic criteria. Stroke 42, 1140-1145 (2011
20. Marks, M. P. et al. Acute and chronic stroke: Navigated spin-echo diffusion-weighted MR imaging. Radiology 199, 403-408 (1996
21. Kucharczyk, J., Mintorovitch, J., Asgari, H. S. & Moseley, M. Diffusion/perfusion MR imaging of acute cerebral ischemia. Magn. Reson. Med. 19, 311-315 (1991
22. Burdette, J. H., Ricci, P. E., Petitti, N. & Elster, A. D. Cerebral infarction: Time course of signal intensity changes on diffusion-weighted MR images. AJR Am. J. Roentgenol. 171, 791-795 (1998
23. Kelley, R. E. & Minagar, A. Cardioembolic stroke: An update. South. Med. J. 96, 343-349 (2003
24. Friberg, L., Hammar, N. & Rosenqvist, M. Stroke in paroxysmal atrial fibrillation: Report from the Stockholm Cohort of Atrial Fibrillation. Eur. Heart J. 31, 967-975 (2010
25. Shinkawa, A. et al. Silent cerebral infarction in a community-based autopsy series in Japan: The Hisayama Study. Stroke 26, 380-385 (1995
26. Gaita, F. et al. Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial fibrillation and correlation with cognitive function. J. Am. Coll. Cardiol. http://dx.doi.org/10.1016/j.jacc.2013.05.074
27. Marfella, R. et al. Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients. J. Am. Coll. Cardiol. 62, 525-520 (2013
28. Kobayashi, A., Iguchi, M., Shimizu, S. & Uchiyama, S. Silent cerebral infarcts and cerebral white matter lesions in patients with nonvalvular atrial fibrillation. J. Stroke Cerebrovasc. Dis. 21, 310-317 (2012
29. Neumann, T. et al. MEDAFI Trial (Micro-Embolization During Ablation of Atrial Fibrillation): Comparison of pulmonary vein isolation using cryoballoon technique vs. radiofrequency energy. Europace 13, 37-44 (2011
30. Sato, H. et al. Aspirin attenuates the incidence of silent brain lesions in patients with nonvalvular atrial fibrillation. Circ. J. 68, 410-416 (2004
31. EAFT Study Group. Silent brain infarction in nonrheumatic atrial fibrillation: European Atrial Fibrillation Trial. Neurology 46, 159-165 (1996
32. Ezekowitz, M. D. et al. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. Circulation 92, 2178-2182 (1995
33. Ott, A. et al. Atrial fibrillation and dementia in a population-based study: The Rotterdam Study. Stroke 28, 316-321 (1997
34. Knecht, S. et al. Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy. Eur. Heart J. 29, 2125-2132 (2008
35. Mielke, M. M. et al. Vascular factors predict rate of progression in Alzheimer disease. Neurology 69, 1850-1858 (2007
36. Santangeli, P. et al. Atrial fibrillation and the risk of incident dementia: A meta-Analysis. Heart Rhythm 9, 1761-1768 (2012
37. Miyasaka, Y. et al. Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: Data from a community-based cohort. Eur. Heart J. 28, 1962-1967 (2007
38. Vaitkus, P. T. & Barnathan, E. S. Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: A meta-Analysis. J. Am. Coll. Cardiol. 22, 1004-1009 (1993
39. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT01556659 (2012
40. Dries, D. L., Rosenberg, Y. D., Waclawiw, M. A. & Domanski, M. J. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: Evidence for gender differences in the studies of left ventricular dysfunction trials. J. Am. Coll. Cardiol. 29, 1074-1080 (1997
41. Siachos, T. et al. Silent strokes in patients with heart failure. J. Card. Fail. 11, 485-489 (2005
42. Koniaris, L. S. & Goldhaber, S. Z. Anticoagulation in dilated cardiomyopathy. J. Am. Coll. Cardiol. 31, 745-748 (1998
43. Kozdag, G. et al. Silent cerebral infarction in patients with dilated cardiomyopathy: Echocardiographic correlates. Int. J. Cardiol. 107, 376-381 (2006
44. Kozdag, G. et al. Silent cerebral infarction in chronic heart failure: Ischemic and nonischemic dilated cardiomyopathy. Vasc. Health Risk Manag. 4, 463-469 (2008
45. Bal, S. et al. High rate of magnetic resonance imaging stroke recurrence in cryptogenic transient ischemic attack and minor stroke patients. Stroke 43, 3387-3388 (2012
46. Foulkes, M. A., Wolf, P. A., Price, T. R., Mohr, J. P. & Hier, D. B. The Stroke Data Bank: Design, methods, and baseline characteristics. Stroke 19, 547-554 (1988
47. Overell, J. R., Bone, I. & Lees, K. R. Interatrial septal abnormalities and stroke: A meta-Analysis of case-control studies. Neurology 55, 1172-1179 (2000
48. Cabanes, L et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age: A study using transesophageal echocardiography. Stroke 24, 1865-1873 (1993
49. Kitsios, G. D., Lasker, A. Singh, J. & Thaler, D. E. Recurrent stroke on imaging and presumed paradoxical embolism: A cross-sectional analysis. Neurology 78, 993-997 (2012
50. Clergeau, MR. et al. Silent cerebral infarcts in patients with pulmonary embolism and a patent foramen ovale: A prospective diffusion-weighted MRI study. Stroke 40, 3758-3762 (2009
51. Ning, M. et al. The brain's heart-Therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease. Pharmacol. Ther. 139, 111-123 (2013
52. Cabanes, L et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 24, 1865-1873 (1993
53. Mas, J. L. et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N. Engl. J. Med. 345, 1740-1746 (2001
54. Davis, D. et al. Patent foramen ovale, ischemic stroke and migraine: Systematic review and stratified meta-Analysis of association studies. Neuroepidemiology 40, 56-67 (2013
55. Handke, M., Harloff, A., Bode, C. & Geibel, A. Patent foramen ovale and cryptogenic stroke: A matter of age? Semin. Thromb. Hemost. 35, 505-514 (2009
56. Lethen, H. et al. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am. J. Cardiol. 80, 1066-1069 (1997
57. Di Tullio, M. R. et al. Patent foramen ovale, subclinical cerebrovascular disease, and ischemic stroke in a population-based cohort. J. Am. Coll. Cardiol. 62, 35-41 (2013
58. Russell, D. & Brucher, R. Online automatic discrimination between solid and gaseous cerebral microemboli with the first multifrequency transcranial Doppler. Stroke 33, 1975-1980 (2002
59. Fuchs, S. et al. Stroke complicating percutaneous coronary interventions: Incidence, predictors, and prognostic implications. Circulation 106, 86-91 (2002
60. Segal, A. Z., Abernethy, W. B., Palacios, I. F., BeLue, R. & Rordorf, G. Stroke as a complication of cardiac catheterization: Risk factors and clinical features. Neurology 56, 975-977 (2001
61. Büsing, K. A. et al. Cerebral infarction: Incidence and risk factors after diagnostic and interventional cardiac catheterization-prospective evaluation at diffusion-weighted MR imaging. Radiology 235, 177-183 (2005
62. Omran, H. et al. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: A prospective, randomised study. Lancet 361, 1241-1246 (2003
63. Lund, C. et al. Cerebral emboli during left heart catheterization may cause acute brain injury. Eur. Heart J. 26, 1269-1275 (2005
64. Ohi, Y. et al. Cerebral microembolism following coronary angiography-A prospective comparative study between left cardiac catheterization and multidetector computed tomography. Intern. Med. 52, 1869-1874 (2013
65. Hamon, M. et al. Silent cerebral infarcts after cardiac catheterization: A randomized comparison of radial and femoral approaches. Am. Heart J. 164, 449-454 (2012
66. Kim, B. J. et al. Insufficient platelet inhibition is related to silent embolic cerebral infarctions after coronary angiography. Stroke 43, 727-732 (2012
67. Kim, I. C. et al. Incidence and predictors of silent embolic cerebral infarction following diagnostic coronary angiography. Int. J. Cardiol. 148, 179-182 (2011
68. Murai, M. et al. Asymptomatic acute ischemic stroke after primary percutaneous coronary intervention in patients with acute coronary syndrome might be caused mainly by manipulating catheters or devices in the ascending aorta, regardless of the approach to the coronary artery. Circ. J. 72, 51-55 (2008
69. Hamon, M. et al. Risk of acute brain injury related to cerebral microembolism during cardiac catheterization performed by right upper limb arterial access. Stroke 38, 2176-2179 (2007
70. Hamon, M. et al., Cerebral microembolism during cardiac catheterization and risk of acute brain injury: A prospective diffusion-weighted magnetic resonance imaging study. Stroke 37, 2035-2038 (2006
71. Sun, X., Lindsay, J., Monsein, L. H., Hill, P. C. & Corso, P. J. Silent brain injury after cardiac surgery: A review: Cognitive dysfunction and magnetic resonance imaging diffusion-weighted imaging findings. J. Am. Coll. Cardiol. 60, 791-797 (2012
72. Keeley, E. C. & Grines, C. L. Scraping of aortic debris by coronary guiding catheters: A prospective evaluation of 1, 000 cases. J. Am. Coll. Cardiol. 32, 1861-1865 (1998
73. Karalis, D. G. et al. Risk of catheter-related emboli in patients with atherosclerotic debris in the thoracic aorta. Am. Heart J. 131, 1149-1155 (1996
74. Webb, J. G. et al. Transcatheter aortic valve implantation: Impact on clinical and valve-related outcomes. Circulation 119, 3009-3016 (2009
75. Grube, E. et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second-And current third-generation self-expanding CoreValve prosthesis: Device success and 30-day clinical outcome. J. Am. Coll. Cardiol. 50, 69-76 (2007
76. Kahlert, P. et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: A diffusion-weighted magnetic resonance imaging study. Circulation 121, 870-878 (2010
77. Rodés-Cabau, J. et al. Cerebral embolism following transcatheter aortic valve implantation: Comparison of transfemoral and transapical approaches. J. Am. Coll. Cardiol. 57, 18-28 (2011
78. Ghanem, A. et al. Prognostic value of cerebral injury following transfemoral aortic valve implantation. EuroIntervention 8, 1296-1306 (2013
79. Fairbairn, T. A. et al. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: Assessment of predictive risk factors and the relationship to subsequent health status. Heart 98, 18-23 (2012
80. Astarci, P. et al. Magnetic resonance imaging evaluation of cerebral embolization during percutaneous aortic valve implantation: Comparison of transfemoral and trans-Apical approaches using Edwards Sapiens valve. Eur. J. Cardiothorac. Surg. 40, 475-479 (2011
81. Ghanem, A. et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: A prospective pilot study with diffusion-weighted magnetic resonance imaging. J. Am. Coll. Cardiol. 55, 1427-1432 (2010
82. Arnold, M. et al. Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging. JACC Cardiovasc. Interv. 3, 1126-1132 (2010
83. Erdoes, G. et al. Transcranial Doppler-detected cerebral embolic load during transcatheter aortic valve implantation. Eur. J. Cardiothorac. Surg. 41, 778-783 (2012
84. Reinsfelt, B. et al. Transcranial Doppler microembolic signals and serum marker evidence of brain injury during transcatheter aortic valve implantation. Acta Anaesthesiol. Scand. 56, 240-247 (2012
85. Kahlert, P. et al. Cerebral embolization during transcatheter aortic valve implantation: A transcranial Doppler study. Circulation 126, 1245-1255 (2012
86. Hynes, B. G. & Rodés-Cabau, J. Transcatheter aortic valve implantation and cerebrovascular events: The current state of the art. Ann. NY Acad. Sci. 1254, 151-163 (2012
87. Knipp, S. C. et al. Cognitive outcomes three years after coronary artery bypass surgery: Relation to diffusion-weighted magnetic resonance imaging. Ann. Thorac. Surg. 85, 872-879 (2008
88. Ito, A. et al. Postoperative neurological complications and risk factors for pre-existing silent brain infarction in elderly patients undergoing coronary artery bypass grafting. J. Anesth. 26, 405-411 (2012
89. Gerriets, T. et al. Evaluation of methods to predict early long-Term neurobehavioral outcome after coronary artery bypass grafting. Am. J. Cardiol. 105, 1095-1101 (2010
90. Bendszus, M. et al. Brain damage after coronary artery bypass grafting. Arch. Neurol. 59, 1090-1095 (2002
91. Lund, C. et al. Cerebral ischemic injury and cognitive impairmentafter off-pump and on-pump coronary artery bypass grafting surgery. Ann. Thorac. Surg. 80, 2126-2131 (2005
92. Wimo, A. et al. The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project. Int. J. Geriatr. Psychiatry 26, 825-832 (2011
93. Blum, S. et al. Memory after silent stroke: Hippocampus and infarcts both matter. Neurology 78, 38-46 (2012
94. Arvanitakis, Z., Leurgans, S. E., Barnes, L. L., Bennett, D. A. & Schneider, J. A. Microinfarct pathology, dementia, and cognitive systems. Stroke 42, 722-727 (2011
95. Gerriets, T. et al. Protecting the brain from gaseous and solid micro-emboli during coronary artery bypass grafting: A randomized controlled trial. Eur. Heart J. 31, 260-268 (2010
96. Djaiani, G. et al. Mild to moderate atheromatous disease of the thoracic aorta and new ischemic brain lesions after conventional coronary artery bypass graft surgery. Stroke 35, e356-e358 (2004
97. Floyd, T. F. et al. Clinically silent cerebral ischemic events after cardiac surgery: Their incidence, regional vascular occurrence, and procedural dependence. Ann. Thorac. Surg. 81, 2160-2166 (2006
98. Selnes, O. A. & McKhann, G. M. Neurocognitive complications after coronary artery bypass surgery. Ann. Neurol. 57, 615-621 (2005
99. Van Dijk, D. et al. Cognitive outcome after off pump and on-pump coronary artery bypass graft surgery: A randomized trial. JAMA 287, 1405-1412 (2002
100. European Heart Rhythm Association. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur. Heart J. 31, 2369-2429 (2010
101. Haeusler, K. G. et al. 3 Tesla MRI-detected brain lesions after pulmonary vein isolation for atrial fibrillation: Results of the MACPAF study. J. Cardiovasc. Electrophysiol. 24, 14-21 (2013
102. Herrera Siklódy, C. et al. Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: Comparison of different atrial fibrillation ablation technologies in a multicenter study. J. Am. Coll. Cardiol. 58, 681-688 (2011
103. Schwarz, N. et al. Neuropsychological decline after catheter ablation of atrial fibrillation. Heart Rhythm. 7, 1761-1767 (2010
104. Gaita, F. et al., Radiofrequency catheter ablation of atrial fibrillation: A cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation. Circulation 122, 1667-1673 (2010
105. Schrickel, J. W. et al. Incidence and predictors of silent cerebral embolism during pulmonary vein catheter ablation for atrial fibrillation. Europace 12, 52-57 (2010
106. Meier, B. et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N. Engl. J. Med. 368, 1083-1091 (2013
107. Carroll, J. D. et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N. Engl. J. Med. 368, 1092-1100 (2013
108. Skowasch, D. et al. Silent and apparent cerebral embolism after interventional closure of symptomatic patent foramen ovale. Int. J. Cardiol. 145, 401-402 (2010
109. Dorenbeck, U. et al. Cerebral embolism with interventional closure of symptomatic patent foramen ovale: An MRI-based study using diffusion-weighted imaging. Eur. J. Neurol. 14, 451-454 (2007
110. Bernick, C. et al. Silent MRI infarcts and the risk of future stroke: The Cardiovascular Health Study. Neurology 57, 1222-1229 (2001
111. Choi, S. H. et al. Diffusion-weighted MRI in vascular dementia. Neurology 54, 83-89 (2000
112. Vermeer, S. E., Longstreth, W. T. Jr & Koudstaal, P. J. Silent brain infarcts: A systematic review. Lancet Neurol. 6, 611-619 (2007
113. Fujikawa, T., Yanai, I. & Yamawaki, S. Psychosocial stressors in patients with major depression and silent cerebral infarction. Stroke 28, 1123-1125 (1997
114. Fujikawa, T., Yamawaki, S. & Touhouda, Y. Incidence of silent cerebral infarction in patients with major depression. Stroke 24, 1631-1634 (1993
115. Yanai, I., Fujikawa, T., Horiguchi, J., Yamawaki, S. & Touhouda, Y. The 3 year course and outcome of patients with major depression and silent cerebral infarction. J. Affect. Disord. 47, 25-30 (1998
116. Fujikawa, T., Yamawaki, S. & Touhouda, Y. Background factors and clinical symptoms of major depression with silent cerebral infarction. Stroke 25, 798-801 (1994